Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-102291
Filing Date
2024-08-30
Accepted
2024-08-30 15:23:08
Documents
2
Period of Report
2024-08-30

Document Format Files

Seq Description Document Type Size
1 6-K 2nd_agreement_abio-x_8.3.htm 6-K 25120
2 EX-99.1 imab-ex99_1.htm EX-99.1 65310
  Complete submission text file 0000950170-24-102291.txt   91456
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 241269420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)